Upstream Bio, Inc.
Clinical Trials
7
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Other: Placebo
- First Posted Date
- 2025-05-20
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- Upstream Bio Inc.
- Target Recruit Count
- 666
- Registration Number
- NCT06981078
- Locations
- 🇺🇸
Qway Research, LLC, Hialeah, Florida, United States
🇺🇸Velocity Clinical Research, Spartanburg - Pulmonology, Spartanburg, South Carolina, United States
🇺🇸Velocity Clinical Research- Union, Union, South Carolina, United States
A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-08-24
- Lead Sponsor
- Upstream Bio Inc.
- Target Recruit Count
- 436
- Registration Number
- NCT06966479
- Locations
- 🇺🇸
Phoenix Medical Research, Miami, Florida, United States
🇺🇸Treasure Valley Medical Research, Boise, Idaho, United States
🇺🇸Metroplex Pulmonary and Sleep Center Drive, McKinney, Texas, United States
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)
- Conditions
- Severe Asthma
- Interventions
- Drug: Verekitug (UPB-101)Drug: Placebo
- First Posted Date
- 2024-01-09
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Upstream Bio Inc.
- Target Recruit Count
- 479
- Registration Number
- NCT06196879
- Locations
- 🇺🇸
AllerVie Clinical Research, Birmingham, Alabama, United States
🇺🇸Kern Research, Inc., Bakersfield, California, United States
🇺🇸Velocity Clinical Research - Lafayette LA, Los Angeles, California, United States
A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps
- Conditions
- Chronic Rhinosinusitis With Nasal Polyps
- First Posted Date
- 2023-12-11
- Last Posted Date
- 2025-08-15
- Lead Sponsor
- Upstream Bio Inc.
- Target Recruit Count
- 45
- Registration Number
- 2023-508231-31-00
- Locations
- 🇨🇿
ORL ambulance MUDr. Pavel Navratil, Olomouc, Czechia
🇨🇿Fakultni Nemocnice Hradec Kralove, Novy Hradec Kralove, Czechia
🇩🇪Universitaetsklinikum Tuebingen AöR, Tuebingen, Germany
Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults
- First Posted Date
- 2022-12-16
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Upstream Bio Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05653479
- Locations
- 🇬🇧
Richmond Pharmacology, London, United Kingdom
- Prev
- 1
- 2
- Next